MeSH tree: D03.633.100.810.050.180
All prescription drugs need a license from a regulator to treat a specific condition. But licensed drugs can be prescribed for conditions they haven't been tested for in a clinical trial. This is known as "off-label" prescribing—and ...
Mar 27, 2024
0
38
The U.S. Centers for Disease Control and Prevention and the Food and Drug Administration say the benefits of receiving a COVID-19 vaccination outweigh the risks.
Jan 29, 2024
1
64
New research at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting, shows that treating rheumatoid arthritis with hydroxychloroquine (HCQ) reduced the risk of nonalcoholic fatty liver disease, ...
Nov 7, 2023
0
64
Leaders of a project to develop and implement equitable new quality measures for lupus care by the end of the decade will present their work at ACR Convergence 2023, the American College of Rheumatology's (ACR) annual meeting.
Nov 7, 2023
0
40
Many people think heavy metals are poisonous and always harm people and the environment. The reality is more nuanced, says Professor Sylvestre Bonnet. In his inaugural lecture he claims that heavy metals can actually help ...
Sep 6, 2023
0
29
French medical bodies on Sunday called on authorities to punish researcher Didier Raoult for "the largest 'unauthorized' clinical trial ever seen" into the use of hydroxychloroquine to treat COVID-19.
May 28, 2023
0
67
Despite the promise of new medications that promote cancer cell death in people with acute myeloid leukemia, leukemic cells often adopt features that let them evade the drugs' effects within a year.
Apr 24, 2023
0
63
Researchers from Johns Hopkins University published a new Journal of Marketing article that examines how receiving negative medical results might affect how people choose between generic and brand name drugs.
Apr 19, 2023
0
52
Preeclampsia is a dangerous complication during pregnancy that endangers both the mother and fetus, but clinicians still don't have an effective way of predicting who will develop it. New research has uncovered a possible ...
Apr 17, 2023
0
41
A new research paper, titled "VCP/p97, a pleiotropic protein regulator of the DNA damage response and proteostasis, is a potential therapeutic target in KRAS-mutant pancreatic cancer," was published in Genes & Cancer on March ...
Mar 24, 2023
0
74
